Glucagon, in concert with insulin, supports the postabsorptive plasma glucose concentration in humans

Diabetes

Volumn 56, Issue 10, 2007, Pages 2442-2448

  Breckenridge, Suzanne M ^a   Cooperberg, Benjamin A ^a   Arbelaez, Ana Maria ^a   Patterson, Bruce W ^a   Cryer, Philip E ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON; GLUCOSE; GROWTH HORMONE; INSULIN; OCTREOTIDE; SODIUM CHLORIDE; SOMATOSTATIN DERIVATIVE;

ABSORPTION; ADULT; ARTICLE; FEMALE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HUMAN EXPERIMENT; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEFICIENCY; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

ADULT; BLOOD GLUCOSE; C-PEPTIDE; FEMALE; GLUCAGON; GLUCOSE; HUMAN GROWTH HORMONE; HUMANS; INFUSIONS, INTRAVENOUS; INSULIN; INTESTINAL ABSORPTION; KINETICS; MALE; OCTREOTIDE; REFERENCE VALUES;

EID: 34948911783     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/db07-0751     Document Type: Article

References (29)

1. Cherrington AD: Control of glucose production in vivo by insulin and glucagon. In Handbook of Physiology, Section 7. The Endocrine System, Volume II. The Endocrine Pancreas and the Regulation of Metabolism. Jefferson LS, Cherrington AD, Eds. New York, Oxford University Press, 2001, p. 759-785
2. Raju B, Cryer PE: Maintenance of the postabsorptive plasma glucose concentration: insulin or insulin plus glucagon? Am J Physiol Endocrinol Metab 289:E181-E186, 2005
3. Liljenquist JE, Mueller GL, Cherrington AD, Keller U, Chiasson J-L, Perry JM, Lacy WW, Rabinowitz D: Evidence for an important role of glucagon in the regulation of hepatic glucose production in normal man. J Clin Invest 59:369-374, 1977
4. Sherwin RS, Hendler R, DeFronzo R, Wahren J, Felig P: Glucose homeostasis during prolonged suppression of glucagon and insulin secretion by somatostatin. Proc Natl Acad Sci U S A 74:348-352,1977
5. Rosen SG, Clutter WE, Shah SD, Miller JP, Bier DM, Cryer PE: Direct, α-adrenergic stimulation of hepatic glucose production in postabsorptive human subjects. Am J Physiol 245:E616-E626, 1983
6. Lins P-E, Efendic S: Hyperglycemia induced by somatostatin in normal subjects. Horm Metab Res 8:497-498, 1976
7. Rosen SG, Clutter WE, Berk MA, Shah SD, Cryer PE: Epinephrine supports the postabsorptive plasma glucose concentration and prevents hypoglycemia when glucagon secretion is deficient in man. J Clin Invest 73:405-411, 1984
8. Petersen KF, Sullivan JT: Effects of a novel glucagon receptor antagonist (BAY 27-9955) on glucagon-stimulated glucose production in humans. Diabetologia 44:2018-2024, 2001
9. Krentz AJ, Boyle PJ, Macdonald LM, Schade DS: Octreotide: a long-acting inhibitor of endogenous hormone secretion for human metabolic investigations. Metabolism 43:24-31, 1994
10. Breckenridge SM, Raju B, Arbelaez AM, Patterson BW, Cooperberg BA, Cryer PE: Basal insulin, glucagon and growth hormone replacement. Am J Physiol Endocrinol Metab. In press
11. Nielsen MF, Nyholm B, Caumo A, Chandramouli V, Schumann WC, Cobelli C, Landau BR, Rizza RA, Schmitz O: Prandial glucose effectiveness and fasting gluconeogenesis in insulin-resistant first-degree relatives of patients with type 2 diabetes. Diabetes 49:2135-2141, 2000
12. Basu R, Schwenk WF, Rizza RA: Both fasting glucose production and disappearance are abnormal in people with "mild" and "severe" type 2 diabetes. Am J Physiol Endocrinol Metab 287:E55-E62, 2004
13. Nielsen MF, Basu R, Wise S, Caumo A, Cobelli C, Rizza RA: Normal glucose-induced suppression of glucose production but impaired stimulation of glucose disposal in type 2 diabetes. Diabetes 47:1735-1747, 1998
14. Kuzuya H, Blix PM, Horwitz DL, Steiner DF, Rubenstein AH: Determination of free and total insulin and C-peptide in insulin-treated diabetics. Diabetes 26:22-29,1977
15. Ensinck J: Immunoassays for glucagon. In Handbook of Experimental Pharmacology. Vol. 66. Lefebrve P, Ed. New York, Springer Verlag, 1983, p. 203-221
16. Gingerich RL, Lacy PE, Chance RE, Johnson MG: Regional pancreatic concentration and in vitro secretion of canine pancreatic polypeptide, insulin and glucagon. Diabetes 27:96-101, 1978
17. Schlach D, Parker M: A sensitive double antibody radioimmunoassay for growth hormone in plasma. Nature 6703:1141-1142, 1964
18. Farmer RW, Pierce CE: Plasma cortisol determination: radioimmunoassay and competitive protein binding compared. Clin Chem 20:411-414, 1974
19. Shah SD, Clutter WE, Cryer PE: External and internal standards in the single isotope derivative (radioenzymatic) measurement of plasma norepinephrine and epinephrine. J Lab Clin Med 106:624-629, 1985
20. Hosaka K, Kikuchi T, Mitsuyhida N, Kawaguchi A: A new colorimetric method for the determination of free fatty acids with acyl-CoA synthase and acyl-CoA oxidase. J Biochem (Tokyo) 89:1799-1803
21. Lowry O, Passoneau J, Hasselberger F, Schultz D: Effect of ischemia on known substrates and co-factors of the glycolytic pathway of the brain. J Biol Chem 239:18-30, 1964
22. Steele R: Influences of glucose loading and of injected insulin on hepatic glucose output. Ann New York Acad Sci 82:420-430, 1959
23. Wolfe RR, Chinkes CL: Isotope Tracers in Metabolic Research. Principles and Practice of Kinetic Analysis. 2nd ed. Hoboken, NJ, John Wiley and Sons, 2005, p. 36-43
24. Rizza R, Verdonk C, Miles J, Service FJ, Haymond M, Gerich J: Somatostatin does not cause sustained fasting hyperglycemia in man. Horm Metab Res 11:643-644, 1979
25. Barnes AJ, Bloom SR: Pancreatechomized man: a model for diabetes without glucagon. Lancet 307:219-221, 1976
26. Muller WA, Berger M, Suter P, Cüppers HJ, Reiter J, Wyss T, Berchtold P, Schmidt FH, Assal J-P, Renold AE: Glucagon immunoreactivities and amino acid profile in plasma of duodenopancreatectomized patients. J Clin Invest 63:820-827, 1979
27. Boden G, Master RW, Rezvani I, Palmer JP, Lobe TE, Owen OE: Glucagon deficiency and hyperaminoacidemia after total pancreatectomy. J Clin Invest 65:706-716, 1980
28. Tiengo A, Bessioud M, Valverde I, Yabbi-Anneni A, Delprato S, Alexandre J, Assan R: Absence of islet alpha cell function in pancreatectomized patients. Diabetologia 22:25-32, 1982
29. Tanjoh K, Tomita R, Fukuzawa M, Hayashi N: Peculiar glucagon processing in the intestine is the genesis of the paradoxical rise of serum pancreatic glucagon in patients after total pancreatectomy. Hepatogastroenterology 50:535-540, 2003